Summit Therapeutics Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
SMMT Nasdaq 2836 www.smmttx.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Summit Therapeutics Inc.

Akeso Confident of Cancer Drug's FDA Approval Odds - Jan 15th, 2026 8:20 pm
AbbVie Enters Cancer Treatment Space via RemeGen Licensing Deal, UBS Says - Jan 13th, 2026 1:06 pm
Is Summit Therapeutics (SMMT) Still Attractive After Recent Pullback And Multi Year Surge - Jan 13th, 2026 11:07 am
Summit Therapeutics (SMMT) Is Down 8.7% After Ivonescimab BLA Filing And Oncology Expansion Update – Has The Bull Case Changed? - Jan 12th, 2026 10:12 pm
2 Biotech Stocks That Could Soar This Year - Jan 12th, 2026 10:05 am
Summit Therapeutics Announces Clinical Trial Collaboration with GSK to Evaluate Ivonescimab in Combination with GSK’s B7-H3 Antibody Drug Conjugate (ADC) - Jan 12th, 2026 4:15 am
Summit Therapeutics Announces Submission of Biologics License Application (BLA) to U.S. FDA Seeking Approval for Ivonescimab in Combination with Chemotherapy in 2L+ Treatment of Patients with EGFRm NSCLC - Jan 12th, 2026 4:00 am
Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Jan 9th, 2026 6:16 pm
A Look At Summit Therapeutics (SMMT) Valuation After Recent Share Price Strength - Jan 7th, 2026 5:17 pm
Stock Market Today, Jan. 6: Alumis Shares Surge on Positive Phase 3 Psoriasis Data for Envudeucitinib - Jan 6th, 2026 3:32 pm
Summit Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference - Jan 6th, 2026 5:30 am
Cantor Fitzgerald Reaffirms Overweight Rating on Summit Therapeutics (SMMT) Before Key 2026 Catalyst - Jan 2nd, 2026 7:10 am
Citi Asserts Buy Rating on Summit Therapeutics Inc. (SMMT) on Pipeline Development - Dec 11th, 2025 9:24 am
Has Summit Therapeutics Rally Left Enough Upside After 448.6% Surge and DCF Upswing? - Dec 11th, 2025 1:14 am
2 Stocks Up Over 600% in the Past 3 Years With More Room to Run - Dec 9th, 2025 3:25 pm
Trading Near Its 52-Week Low, Is Summit Therapeutics a Good Stock to Buy Right Now? - Dec 5th, 2025 11:25 am
Don't Buy Summit Therapeutics Until This Big Thing Happen - Dec 3rd, 2025 2:44 am
Widening Q3 Losses and Insider Buying Might Change The Case For Investing In Summit Therapeutics (SMMT) - Dec 2nd, 2025 6:10 pm
Summit Therapeutics (SMMT): Valuation Check After Weak Q3 2025 Results and Insider Share Purchases - Dec 2nd, 2025 5:14 pm
2 Monster Stocks in the Making to Buy and Hold - Dec 2nd, 2025 5:00 am